About one in four pregnancies ends in pregnancy loss. For many people this can be an emotional process, and it is important that they receive care in a setting that is comfortable and safe. RHAP believes that everyone experiencing early pregnancy loss should be able to access high-quality, patient-centered care within their own communities, from their own clinicians. Too often, people experiencing an early pregnancy loss are sent to the emergency room for treatment, which can be frightening, costly, and traumatizing during this difficult time. With the right training and support, family physicians and other primary care providers can treat early pregnancy loss in their own clinic settings.
RHAP is committed to improving access to and understanding of all three forms of care for early pregnancy loss within primary care: expectant, medication management, and uterine aspiration. In June 2018, an article published in The New England Journal of Medicine revealed a more effective method of medication management for early pregnancy loss than the standard of care. The study results demonstrated that using mifepristone followed by misoprostol was more effective than using misoprostol alone. RHAP believes that all patients experiencing an early pregnancy loss deserve to be treated with the most up to date recommendations. Through our research, clinical resources, and the Miscarriage Care Initiative, we work closely with family physicians and other primary care providers to ensure that they have the tools and resources to offer the most up to date care to their patients. This fall, RHAP will be updating all of our materials to reflect this new protocol for medication management of early pregnancy loss, including creating a page on our website to support clinicians in adopting this new recommendation. Please keep your eye out for our new and updated resources on medication management of early pregnancy loss.